These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26095811)

  • 21. [Triplet expansion cytosine-guanine-guanine: Three cases of OMIM syndrome in the same family].
    González-Pérez J; Izquierdo-Álvarez S; Fuertes-Rodrigo C; Monge-Galindo L; Peña-Segura JL; López-Pisón FJ
    Med Clin (Barc); 2016 Apr; 146(7):311-5. PubMed ID: 26776484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood expression profiles of fragile X premutation carriers identify candidate genes involved in neurodegenerative and infertility phenotypes.
    Mateu-Huertas E; Rodriguez-Revenga L; Alvarez-Mora MI; Madrigal I; Willemsen R; Milà M; Martí E; Estivill X
    Neurobiol Dis; 2014 May; 65():43-54. PubMed ID: 24418349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathophysiology Mechanisms in Fragile-X Primary Ovarian Insufficiency.
    Elizur SE; Friedman Gohas M; Dratviman-Storobinsky O; Cohen Y
    Methods Mol Biol; 2019; 1942():165-171. PubMed ID: 30900184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential increases of specific FMR1 mRNA isoforms in premutation carriers.
    Pretto DI; Eid JS; Yrigollen CM; Tang HT; Loomis EW; Raske C; Durbin-Johnson B; Hagerman PJ; Tassone F
    J Med Genet; 2015 Jan; 52(1):42-52. PubMed ID: 25358671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of human-derived stem cells to create a novel, in vitro model designed to explore FMR1 CGG repeat instability amongst female premutation carriers.
    Gustin SLF; Wang G; Baker VM; Latham G; Sebastiano V
    J Assist Reprod Genet; 2018 Aug; 35(8):1443-1455. PubMed ID: 29926373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Curvilinear association of CGG repeats and age at menopause in women with FMR1 premutation expansions.
    Mailick MR; Hong J; Greenberg J; Smith L; Sherman S
    Am J Med Genet B Neuropsychiatr Genet; 2014 Dec; 165B(8):705-11. PubMed ID: 25346430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identifying susceptibility genes for primary ovarian insufficiency on the high-risk genetic background of a fragile X premutation.
    Trevino CE; Rounds JC; Charen K; Shubeck L; Hipp HS; Spencer JB; Johnston HR; Cutler DJ; Zwick ME; Epstein MP; Murray A; Macpherson JN; Mila M; Rodriguez-Revenga L; Berry-Kravis E; Hall DA; Leehey MA; Liu Y; Welt C; Warren ST; Sherman SL; Jin P; Allen EG
    Fertil Steril; 2021 Sep; 116(3):843-854. PubMed ID: 34016428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dysregulation of anti-Mullerian hormone expression levels in mural granulosa cells of FMR1 premutation carriers.
    Friedman-Gohas M; Orvieto R; Michaeli A; Aizer A; Kirshenbaum M; Cohen Y
    Sci Rep; 2021 Jul; 11(1):14139. PubMed ID: 34238973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Refining the risk for fragile X-associated primary ovarian insufficiency (FXPOI) by FMR1 CGG repeat size.
    Allen EG; Charen K; Hipp HS; Shubeck L; Amin A; He W; Nolin SL; Glicksman A; Tortora N; McKinnon B; Shelly KE; Sherman SL
    Genet Med; 2021 Sep; 23(9):1648-1655. PubMed ID: 33927378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fragile X-associated primary ovarian insufficiency: evidence for additional genetic contributions to severity.
    Hunter JE; Epstein MP; Tinker SW; Charen KH; Sherman SL
    Genet Epidemiol; 2008 Sep; 32(6):553-9. PubMed ID: 18357616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Penetrance of FMR1 premutation associated pathologies in fragile X syndrome families.
    Rodriguez-Revenga L; Madrigal I; Pagonabarraga J; Xunclà M; Badenas C; Kulisevsky J; Gomez B; Milà M
    Eur J Hum Genet; 2009 Oct; 17(10):1359-62. PubMed ID: 19367323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Heterogeneity of clinical characteristics of FMR1-related disorders].
    Pereverzeva DS; Tyushkevich SA; Gorbachevskaya NL; Mamokhina UA; Danilina KK
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(7):103-111. PubMed ID: 31464297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What is the threshold of mature oocytes to obtain at least one healthy transferable cleavage-stage embryo after preimplantation genetic testing for fragile X syndrome?
    Sonigo C; Mayeur A; Sadoun M; Pinto M; Benguigui J; Frydman N; Monnot S; Benachi A; Steffann J; Grynberg M
    Hum Reprod; 2021 Oct; 36(11):3003-3013. PubMed ID: 34568938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ovarian abnormalities in a mouse model of fragile X primary ovarian insufficiency.
    Hoffman GE; Le WW; Entezam A; Otsuka N; Tong ZB; Nelson L; Flaws JA; McDonald JH; Jafar S; Usdin K
    J Histochem Cytochem; 2012 Jun; 60(6):439-56. PubMed ID: 22470123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FMRP Associates with Cytoplasmic Granules at the Onset of Meiosis in the Human Oocyte.
    Rosario R; Filis P; Tessyman V; Kinnell H; Childs AJ; Gray NK; Anderson RA
    PLoS One; 2016; 11(10):e0163987. PubMed ID: 27695106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clustering of comorbid conditions among women who carry an FMR1 premutation.
    Allen EG; Charen K; Hipp HS; Shubeck L; Amin A; He W; Hunter JE; Sherman SL
    Genet Med; 2020 Apr; 22(4):758-766. PubMed ID: 31896764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The FMR1 premutation and reproduction.
    Wittenberger MD; Hagerman RJ; Sherman SL; McConkie-Rosell A; Welt CK; Rebar RW; Corrigan EC; Simpson JL; Nelson LM
    Fertil Steril; 2007 Mar; 87(3):456-65. PubMed ID: 17074338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Carriers of fragile X syndrome can present with a broad spectrum of clinical disorders].
    Jønch AE; Grønskov K; Carlsen Lunding JM; Nielsen JE; Brøndum-Nielsen K
    Ugeskr Laeger; 2014 Jun; 176(26):V02140099. PubMed ID: 25294575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of FMR4, FMR5 and FMR6 Expression Levels as Non-Invasive Biomarkers for the Diagnosis of Fragile X-Associated Primary Ovarian Insufficiency (FXPOI).
    Alvarez-Mora MI; Agusti I; Wijngaard R; Martinez-Barrios E; Barcos T; Borras A; Peralta S; Guimera M; Goday A; Manau D; Rodriguez-Revenga L
    J Clin Med; 2022 Apr; 11(8):. PubMed ID: 35456280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reproductive and gynecologic care of women with fragile X primary ovarian insufficiency (FXPOI).
    Hipp HS; Charen KH; Spencer JB; Allen EG; Sherman SL
    Menopause; 2016 Sep; 23(9):993-9. PubMed ID: 27552334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.